|
|
|
|
Producing MSC-Derived Cell Therapies From Isolation To Large-Scale Expansion: Workflows, Technologies, And Case Studies
Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.
|
|
|
|
|
MSCulture Max™ Media Frequently Asked Questions
Optimize your MSC expansion with media that eliminates the need for cell feeding between passages. Learn about the three available versions and their key features.
|
|
|
|
|
Expansion Of Human Bone Marrow-Derived MSCs With Corning MSCulture Max™-XF Media And HYPERStack Cell Culture Vessels
Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.
|
|
|
|
|
Expansion Of Human Umbilical Cord-Derived MSCs With Corning MSCulture Max™-XF Media And HYPERStack 36-Layer Vessels
Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.
|
|
|
|
|
From Bench To Bioproduction: Scalable MSC Expansion
Scalable MSC expansion requires balancing high productivity with biological consistency. Explore data-driven strategies for robust, reproducible growth from early research to process-ready platforms.
|
|
|
|
|
|
|
MSCulture Max™ Media
Accelerate your stem cell research with a high-performance media that eliminates exchanges, boosts cell yields over 10-fold, and supports seamless translation from bench to clinic.
|
|
|
